In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemiaJaebok Choi, John F. DiPersio, Julie L. Prior et al.|Blood|2010Cited by 306
BI-5756 Reduces Graft-Versus-Host Disease Through CB1-Mediated Treg UpregulationSena Kim, Jaebok Choi|Molecules|2025Cited by 0